SEPARATION AGREEMENTSeparation Agreement • March 1st, 2017 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New Jersey
SEPARATION AGREEMENT, dated January 12, 2017, between Valeant Pharmaceuticals International, Inc. (“Valeant” or the “Company”) and Ari S. Kellen (“Employee” and together with Valeant, the “Parties”).
SEPARATION AGREEMENTSeparation Agreement • March 1st, 2017 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New Jersey
SEPARATION AGREEMENT, dated August 8, 2016 (the “Effective Date”), between Valeant Pharmaceuticals International, Inc. (“Valeant”) and Robert R. Chai-Onn (“Employee” and together with Valeant, the “Parties”).
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT (RESTRICTED STOCK UNITS)Valeant Pharmaceuticals International, Inc. • March 1st, 2017 • Pharmaceutical preparations • Ontario
Valeant Pharmaceuticals International, Inc. (the “Company”), pursuant to the Company’s 2014 Omnibus Incentive Plan (the “Plan”), hereby awards to you a Restricted Stock Unit Award in the form of restricted share units (the “Restricted Stock Units” or the “Award”), payable in common shares of the Company (“Common Shares”), covering the number of Common Shares set forth below. This Award is subject to all of the terms and conditions as set forth herein (the “Award Agreement”) and in the Plan, which is incorporated herein in its entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any conflict between the terms in the Award Agreement and the Plan, the terms of the Plan shall control. For the avoidance of doubt, any terms contained in the Award Agreement but are not in the Plan shall not constitute a conflict and such terms in the Award Agreement shall control.
September 28, 2016 Joseph C. Papa Chairman and Chief Executive Officer Valeant Pharmaceuticals International, Inc. Dear Joe:Employment Agreement • March 1st, 2017 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations
Reference is made to my retention letter agreement from you on behalf of Valeant Pharmaceuticals International, Inc. (the “Company”) dated May 6, 2016 (my “Retention Agreement”), which amends the terms of my employment letter agreement from the Company dated June 10, 2015 (my “Employment Agreement”) for the period between May 6, 2016 and December 31, 2016.
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. MAKE-WHOLE AWARD AGREEMENT (RESTRICTED STOCK UNITS)Valeant Pharmaceuticals International, Inc. • March 1st, 2017 • Pharmaceutical preparations • Ontario
Valeant Pharmaceuticals International, Inc. (the “Company”), pursuant to the Company’s 2014 Omnibus Incentive Plan (the “Plan”), hereby awards to you a Make-Whole Award in the form of restricted share units (the “Restricted Stock Units” or the “Award”), payable in common shares of the Company (“Common Shares”), covering the number of Common Shares set forth below. This Award is subject to all of the terms and conditions as set forth herein (the “Award Agreement”) and in the Plan, which is incorporated herein in its entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any conflict between the terms in the Award Agreement and the Plan, the terms of the Plan shall control. For the avoidance of doubt, any terms contained in the Award Agreement but are not in the Plan shall not constitute a conflict and such terms in the Award Agreement shall control.
SEPARATION AGREEMENTSeparation Agreement • March 1st, 2017 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New Jersey
SEPARATION AGREEMENT, dated February 7, 2017, between Valeant Pharmaceuticals International, Inc. (“Valeant”) and Anne C. Whitaker (“Employee” and together with Valeant, the “Parties”).
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FORM OF STOCK OPTION GRANT AGREEMENT (NONSTATUTORY STOCK OPTION) (2014 Omnibus Incentive Plan)Stock Option Grant Agreement • March 1st, 2017 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Ontario
Valeant Pharmaceuticals International, Inc. (the “Company”), pursuant to its 2014 Omnibus Incentive Plan (the “Plan”), hereby grants to you an option to purchase the number of Common Shares set forth below (the “Award”). This Award is subject to all of the terms and conditions as set forth herein (the “Agreement”) and in the Plan, which is incorporated herein in its entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any conflict between the terms in the Agreement and the Plan, the terms of the Plan shall control. For the avoidance of doubt, any terms contained in the Agreement but are not in the Plan shall not constitute a conflict and such terms in the Agreement shall control.
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FORM OF SHARE UNIT GRANT AGREEMENT (PERFORMANCE VESTING) (PERFORMANCE RESTRICTED SHARE UNITS) (2014 Omnibus Incentive Plan)Valeant Pharmaceuticals International, Inc. • March 1st, 2017 • Pharmaceutical preparations • Ontario
Valeant Pharmaceuticals International, Inc. (the “Company”), pursuant to Section 7(c)(v) of the Company’s 2014 Omnibus Incentive Plan (including the Addendum thereto) (the “Plan”), hereby awards to you a Share Unit in the amount set forth below convertible into Common Shares in accordance with the terms set forth herein (the “Award”). This Award is subject to all of the terms and conditions as set forth herein (the “Agreement”) and in the Plan, which is incorporated herein in its entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any conflict between the terms in the Agreement and the Plan, the terms of the Plan shall control. For avoidance of doubt, any terms contained in the Agreement but are not in the Plan shall not constitute a conflict and such terms in the Agreement shall control.
